KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Shares Outstanding (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Shares Outstanding for 11 consecutive years, with $34.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 2.64% to $34.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.5 million through Dec 2025, up 2.64% year-over-year, with the annual reading at $34.5 million for FY2025, 11.87% up from the prior year.
  • Shares Outstanding hit $34.5 million in Q4 2025 for Fulgent Genetics, up from $34.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $34.5 million in Q4 2025 to a low of $29.0 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $30.5 million across 5 years, with a median of $30.1 million in 2021.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 35.32% in 2021 and later dropped 2.39% in 2022.
  • Year by year, Shares Outstanding stood at $30.2 million in 2021, then fell by 2.39% to $29.4 million in 2022, then increased by 0.73% to $29.7 million in 2023, then rose by 13.36% to $33.6 million in 2024, then grew by 2.64% to $34.5 million in 2025.
  • Business Quant data shows Shares Outstanding for FLGT at $34.5 million in Q4 2025, $34.3 million in Q3 2025, and $30.6 million in Q2 2025.